AHA: Drilling Down in JUPITER Confirms Benefit for Women (CME/CE)

ORLANDO (MedPage Today) A subset analysis of data from the JUPITER trial indicates that apparently healthy women treated with rosuvastatin (Crestor) reduced their relative risk of major cardiovascular events by 46%, slightly higher than the 42% reduction seen in men.

source : www.medpagetoday.com

Related News:

• SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)

Details :
Submited at Thursday, November 19th, 2009 at 7:00 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback